C4 and Alphabet’s Calico hook up on aging
Alphabet company Calico and biotech startup C4 Therapeutics (C4T) join forces to tackle age-related diseases including cancer. This collaboration will use C4T’s expertise to discover small molecule candidates. Calico will then advance these candidates into development and commercialization.
Dana-Farber Cancer Institute’s C4 Therapeutics focuses on disorders that are difficult-to-treat and diseases where drug resistance is a challenge. Calico focuses on developing drugs and technologies that help people to live longer and better.
